NL
MRNA icon

NVWM LLC’s Moderna MRNA Stock Holding History

NVWM LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.58K Buy
29
+5
+21% +$539 ﹤0.01% 424
2026
Q2 		$1.68K Hold
24
– – ﹤0.01% 537
2026
Q1 		$1.22K Hold
24
– – ﹤0.01% 544
2025
Q4 		$708 Hold
24
– – ﹤0.01% 611
2025
Q3 		$620 Buy
24
+19
+380% +$530 ﹤0.01% 577
2025
Q2 		$138 Sell
5
-11
-69% -$290 ﹤0.01% 656
2025
Q1 		$454 Buy
16
+6
+60% +$213 ﹤0.01% 576
2024
Q4 		$416 Buy
+10
New +$478 ﹤0.01% 579
2024
Q3 		– Sell
-9,092
Closed -$1.08M – 672
2024
Q2 		$1.08M Sell
9,092
-84
-0.9% -$10.6K 0.29% 106
2024
Q1 		$978K Buy
9,176
+5,838
+175% +$588K 0.27% 117
2023
Q4 		$332K Sell
3,338
-306
-8% -$25.7K 0.1% 177
2023
Q3 		$376K Sell
3,644
-2,871
-44% -$320K 0.12% 167
2023
Q2 		$792K Buy
6,515
+2,403
+58% +$321K 0.26% 125
2023
Q1 		$632K Buy
+4,112
New +$678K 0.21% 141
2022
Q1 		– Sell
-23
Closed -$6K – 585
2021
Q4 		$6K Sell
23
-4,032
-99% -$1.18M ﹤0.01% 424
2021
Q3 		$1.56M Sell
4,055
-952
-19% -$351K 0.56% 43
2021
Q2 		$1.18M Buy
5,007
+100
+2% +$17.9K 0.42% 75
2021
Q1 		$643K Buy
4,907
+146
+3% +$21.2K 0.26% 140
2020
Q4 		$498K Sell
4,761
-10,542
-69% -$1.07M 0.21% 131
2020
Q3 		$1.08M Sell
15,303
-14
-0.1% -$976 0.51% 55
2020
Q2 		$983K Sell
15,317
-8,228
-35% -$451K 0.53% 58
2020
Q1 		$705K Buy
+23,545
New +$542K 0.49% 61

Other funds holding MRNA

Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BVL
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
PFM
Patton Fund Management Dallas, Texas $389M AUM 65.14% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $187M AUM 21.63% 1-Year Est. Return
NIM
Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return
BSCCG
Blue Sky Capital Consultants Group Poway, California $239M AUM 14.34% 1-Year Est. Return

NVWM LLC's MRNA Position: Q3 2026 in Review

NVWM LLC increased its Moderna (MRNA) stake by 21% in Q3 2026, buying an estimated $539 and bringing the position to 29 shares worth $5.58K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

NVWM LLC first reported a position in MRNA in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.56M in Q3 2021. 92 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • NVWM LLC held 29 shares of Moderna worth $5.58K as of Q3 2026.
  • NVWM LLC bought 5 Moderna shares in Q3 2026, an estimated $539.
  • Moderna made up ﹤0.01% of NVWM LLC's portfolio in Q3 2026, its #424 holding.
  • NVWM LLC first reported a position in Moderna in Q1 2020 and has held it in 22 quarters since.
  • NVWM LLC's Moderna position peaked at $1.56M in Q3 2021.
  • 92 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.